Praxis Precision Medicines Inc (PRAX)
45.27
+0.06
(+0.13%)
USD |
NASDAQ |
May 17, 16:00
45.27
0.00 (0.00%)
After-Hours: 20:00
Praxis Precision Medicines Total Liabilities (Quarterly): 20.73M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 20.73M |
| December 31, 2023 | 18.28M |
| September 30, 2023 | 19.97M |
| June 30, 2023 | 27.87M |
| March 31, 2023 | 33.92M |
| December 31, 2022 | 39.02M |
| September 30, 2022 | 31.74M |
| June 30, 2022 | 41.55M |
| March 31, 2022 | 48.48M |
| Date | Value |
|---|---|
| December 31, 2021 | 41.94M |
| September 30, 2021 | 28.49M |
| June 30, 2021 | 19.74M |
| March 31, 2021 | 13.74M |
| December 31, 2020 | 15.72M |
| September 30, 2020 | 10.58M |
| June 30, 2020 | 8.547M |
| December 31, 2019 | 7.581M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
7.581M
Minimum
Dec 2019
48.48M
Maximum
Mar 2022
25.17M
Average
20.73M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 85.26M |
| Regeneron Pharmaceuticals Inc | 7.378B |
| Atossa Therapeutics Inc | 5.328M |
| ADMA Biologics Inc | 197.17M |
| Viking Therapeutics Inc | 33.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 250.41M |
| Shareholders Equity (Quarterly) | 229.68M |
| Current Ratio | 11.27 |